apolipoprotein AI analogs (Fournier)

N/A

Report date: 2025/03/17 20:00:36
NME

Base Information

Drug Nameapolipoprotein AI analogs (Fournier)
Drug Alias NameApo-AI analogs (Fournier)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsAtherosclerosisShock, Septic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesFournier Pharma Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesFournier Pharma Corp
Active IndicationsN/A
Inactive IndicationsAtherosclerosisShock, Septic

Other Information

ATC CodeN/A
Related LinksN/A